Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment

NCT05334290 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-03-12

No results posted yet for this study

Summary

The aim of this study is to evaluate the financial toxicity reported by Italian patients affected by GEP-NEN during the first year of treatment after diagnosis and its correlations with patient-reported outcomes (PROs) and quality of life (QoL).

Conditions

Sponsors & Collaborators

  • Massimo Falconi

    lead OTHER

Principal Investigators

  • Stefano Partelli, Professor · San Raffaele Hospital Milan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-06
Primary Completion
2023-10-05
Completion
2024-08-05

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05334290 on ClinicalTrials.gov